Arkolith/Insider Trading/AADI/Form 4

Desai Neil

Executive Chairman, Director, 10% OwnerAadi Bioscience, Inc. (AADI) · full profile →Form 4 · filed Jun 5, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$279K
Net Open-Market Flow
-$279K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 5, 2023Sell(S)17K$8.11$140K1.8M
Jun 2, 2023Sell(S)12K$7.99$99K1.8M
Jun 1, 2023Sell(S)5K$7.92$39K1.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-034632) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML